Benzinga | Aug 3, 2021 08:49AM EDT

aTyr Pharma Granted U.S. Patent Titled 'Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities'

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5497&f=G&l=50&d=PTXT&p=110&S1=20210803&OS=20210803&RS=20210803